TSE draft guidance
FDA's Transmissible Spongiform Encephalopathies Advisory Committee will discuss amino acid production and FDA's draft guidance on revised preventative measures for the transmission of Creutzfeldt-Jakob disease Oct. 25. The risk of transmission of BSE through bovine brains and other neurological tissue will be discussed Oct. 26. The meeting will be held at the Holiday Inn, Silver Spring, Md. at 8 a.m
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth